Related Experiment Videos

The Effect of Eliminating Intermediate Severity Drug-Drug Interaction Alerts on Overall Medication Alert Burden and

Amy M Knight1, Joyce Maygers2, Kimberly A Foltz3

  • 1Division of Hospital Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.

Abstract

Insights

Reducing drug-drug interaction (DDI) alerts in electronic health systems significantly decreased alert burden and improved alert acceptance. However, overall alert acceptance rates remain low, indicating a need for further optimization.

Area of Science:

  • Health Informatics
  • Clinical Pharmacy
  • Patient Safety

Background:

  • Electronic health systems generate numerous drug-drug interaction (DDI) alerts, potentially leading to alert fatigue.
  • High alert rates can decrease clinician trust and acceptance of critical warnings.

Purpose of the Study:

  • To evaluate the impact of reducing DDI alert frequency on alert burden and acceptance rates.
  • To assess changes in medication alert acceptance after modifying DDI alert thresholds.

Main Methods:

  • A retrospective pre-post analysis was conducted at an urban medical center.
  • The study compared alert rates and acceptance over two 5-month periods before and after changing the DDI alert threshold from 'intermediate' to 'severe'.
  • Analysis focused on orders generating single alerts to discern response variations.

Main Results:

  • The intervention resulted in a 37.5% relative decrease in overall alert rates and a 39.6% relative increase in alert acceptance.
  • For single alerts, there was a 69.1% relative decrease in alert generation and an 85.7% relative increase in acceptance.
  • Despite relative improvements, absolute increases in alert acceptance were modest (2.1% overall, 1.8% for single alerts).

Conclusions:

  • Modifying DDI alert thresholds to exclude intermediate severity alerts significantly reduces alert burden.
  • This change also increases the rate of medication alert acceptance.
  • Alert acceptance rates remain low overall, suggesting that further strategies are needed to optimize DDI alert systems.

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.5K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
189
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
216
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.8K
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
170
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
296